Identifcation of Biomarkers for Active Pulmonary Tuberculosis

Identifcation of Biomarkers for Active Pulmonary Tuberculosis Using a Metabolomics Approach: a Prospective Multicenter Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04490746

Enrollment

100

Registered

2020-07-29

Start date

2020-10-01

Completion date

2022-10-01

Last updated

2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis, Tuberculosis

Brief summary

This experiment is designed to analyze the metabolites in body fluids from patients with active tuberculosis and latent tuberculosis infection also with health volunteer, then combine the metabolic product features with clinical characteristics, to develop a kind of metabolites targets to evaluate the progress in tuberculosis, thus provide a basis for further utilization of humoral metabolites in the diagnosis of tuberculosis.

Interventions

OTHERwith no intervention, Collect samples

only with observation,there is no need to intervene

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* patients with active tuberculosis and latent tuberculosis infection

Exclusion criteria

* have other serious health problems

Design outcomes

Primary

Measure	Time frame	Description
metabolic product	24 hours after sampling	features up-regulated or down-regulated

Countries

China

Contacts

Primary ContactYajing Liu

liuyajingyyyyy@126.com18358152521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026